Loading patent…
AssigneeEisai R&D Management Co., Ltd.
InventorsMark Bock, Ming-Hong Hao, Manav Korpal, Vijay Kumar Nyavanandi, Xiaoling Puyang, Susanta Samajdar, Peter Gerard Smith, John Wang, Guo Zhu Zheng, Ping Zhu, Lorna Helen Mitchell, Nicholas Larsen, Nathalie Rioux
Estimating the term…
Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.
(canceled)
A compound of Formula (X):
A compound or pharmaceutically acceptable salt selected from the group consisting of:
A compound of Formula (XII) or a pharmaceutically acceptable salt thereof:
Dependencies are inferred from the claim text.